ANZCTR search results

These search results are from the Australian New Zealand Clinical Trials Registry (ANZCTR).

You can narrow down the results using the filters

First, select a broad health condition.
31620 results sorted by trial registration date.
Clear all

  • Activity, Diet and Blood Pressure Trial

    Intervention and 1-year follow-up have been completed. Further 2-year follow-up is in progress.

    Registration number:
    ACTRN12605000090617
    Broad health category:
    • Cardiovascular
    Specific health category:
    • Hypertension
    Trial focus:
    • Treatment
    Recruitment status:
    • Active, not recruiting
    Recruitment sites:
    • Not specified
    Gender:
    • All

  • Neurobiological effects of sleep apnea and sleepiness

    Registration number:
    ACTRN12605000089639
    Broad health category:
    • Respiratory
    Specific health category:
    • Sleep apnoea
    Trial focus:
    • Not specified
    Recruitment status:
    • Completed
    Recruitment sites:
    • Not specified
    Gender:
    • All

  • Effects of fish oil and coenzyme Q10 on cardiovascular risk in chronic renal failure

    The study aims to determine if supplementation with fish oils or the vitamin coenzyme Q10, or a combination of both, will lead to beneficial effects on blood pressure and heart disease risk in patients with renal impairment. Heart disease is one of the main causes of death in Australia. People with renal impairment are at increased cardiovascular risk due to the coexistence of hypertension (high blood pressure), blood lipid abnormalities (blood fats) and increased inflammation. One approach may be to complement drug treatment of renal impairment with non-drug measures such as nutrition and lifestyle factors. In this regard, fish oils have great clinical potential in the treatment of renal impairment and its associated complications. Fish oils reduce blood pressure and improve blood vessel wall elasticity. They improve blood fats, reduce the tendency of blood to clot and reduce inflammation. Coenzyme Q10 is a vitamin that plays a critical role in cell function. It improves blood pressure, blood vessel and heart function, and glucose control.

    Registration number:
    ACTRN12605000088640
    Broad health category:
    • Renal and Urogenital
    Specific health category:
    • Other renal and urogenital disorders
    Trial focus:
    • Prevention
    Recruitment status:
    • Completed
    Recruitment sites:
    • WA
    Gender:
    • All

  • Effects of circadian disruption and sleep deprivation in respiratory disorders

    Registration number:
    ACTRN12605000087651
    Broad health category:
    • Respiratory
    Specific health category:
    • Sleep apnoea
    • Asthma
    Trial focus:
    • Prevention
    Recruitment status:
    • Withdrawn
    Recruitment sites:
    • Not specified
    Gender:
    • All

  • Effects of circadian disruption and sleep deprivation in respiratory disorders

    Registration number:
    ACTRN12605000086662
    Broad health category:
    • Respiratory
    Specific health category:
    • Sleep apnoea
    • Asthma
    Trial focus:
    • Prevention
    Recruitment status:
    • Withdrawn
    Recruitment sites:
    • Not specified
    Gender:
    • All

  • SIMPLE LIFESTYLE STRATEGIES TO TREAT OBSTRUCTIVE SLEEP APNOEA

    Subjects randomly allocated to receive either active, aggressive diet and exercise program or simple information sheet only, for 4 months

    Registration number:
    ACTRN12605000085673
    Broad health category:
    • Respiratory
    Specific health category:
    • Sleep apnoea
    Trial focus:
    • Treatment
    Recruitment status:
    • Stopped early
    Recruitment sites:
    • Not specified
    Gender:
    • All

  • EVALUATION OF THE UTILITY AND COST OF A HOME-BASED PORTABLE POLYSOMNOGRAPHY SYSTEM.

    Sleep studies on 4 consecutive nights, 2 in-lab, 2 at-home, in random order

    Registration number:
    ACTRN12605000084684
    Broad health category:
    • Respiratory
    Specific health category:
    • Sleep apnoea
    Trial focus:
    • Diagnosis
    Recruitment status:
    • Recruiting
    Recruitment sites:
    • Not specified
    Gender:
    • All

  • THE INTERACTIONS BETWEEN SLEEP DISORDERED BREATHING, METABOLIC SYNDROME AND VASCULAR RISK

    Registration number:
    ACTRN12605000083695
    Broad health category:
    • Metabolic and Endocrine
    • Respiratory
    Specific health category:
    • Metabolic disorders
    • Sleep apnoea
    Trial focus:
    • Treatment
    Recruitment status:
    • Recruiting
    Recruitment sites:
    • Not specified
    Gender:
    • All

  • INSTEP Trial

    For pain relief after VATS pleurodesis, patients are given either Celebrex or Placebo for 5 days plus any other required analgesics. We aim to determine whether there is any difference in failure of the lung to adhere to the lining of the chest.

    Registration number:
    ACTRN12605000082606
    Broad health category:
    • Respiratory
    • Surgery
    Specific health category:
    • Other respiratory disorders / diseases
    • Other surgery
    Trial focus:
    • Treatment
    Recruitment status:
    • Recruiting
    Recruitment sites:
    • VIC
    Gender:
    • All

  • HATS trial

    To determine whether a new form of minimally invasive ("keyhole") surgery results in less pain and suffering than traditional surgery of the lung via thoracotomy.

    Registration number:
    ACTRN12605000081617
    Broad health category:
    • Cancer
    Specific health category:
    • Not specified
    Trial focus:
    • Treatment
    Recruitment status:
    • Completed
    Recruitment sites:
    • Not specified
    Gender:
    • All
Tags:
  • Finding clinical trials